Strategic Partner to the REMS Industry Consortium
Buchanan Ingersoll & Rooney
Buchanan Ingersoll & Rooney is a national law firm that serves as legal counsel to the REMS Industry Consortium. Buchanan advises on FDA Regulatory, Antitrust, Corporate, Governance and other issues, as well as strategy in advancing the RIC mission.
Linda Pissott Reig, Shareholder, leads Buchanan's RIC team. Ms. Reig co-chairs Buchanan's FDA Section and advises companies on the development and sale of FDA-regulated products, including research-related topics, as well as marketing and sale of prescription drugs and medical devices. Ms. Reig is a former pharmaceutical products liability litigator and seven-year author of the "Risk Evaluation and Mitigation Strategies ("REMS") and Related Post-Market Safety Oversight" chapter in the annually-released Pharmaceutical Compliance and Enforcement Answer Book (Practising Law Institute).
Jason R. Parish, Shareholder, co-leads Buchanan’s Life Sciences team and serves as lead Antitrust counsel to the RIC Board of Directors. Mr. Parish is a trial lawyer who manages complex litigation involving pharmaceutical and healthcare entities. He has extensive experience in high-stakes, "bet the company" matters involving DOJ, FTC, HHS, OIG, CMS and other government investigations.
Richard DiStefano, Shareholder, leads the RIC efforts in corporate formation and governance. Mr. DiStefano has extensive experience representing pharmaceutical and biopharmaceutical companies with a focus on corporate finance, M&A, capital markets and general corporate representation as well as commercial transactions, compliance and other matters.